top of page
  • Writer's pictureLaurent DECORY

Among 2019 top 10 Biotech IPOs, 5 reached more than 1 $Bn valuation

Updated: Mar 24, 2020

Among 2019 top 10 Biotech IPOs Genmab's $505 million came #1, while BridgeBio Pharma, Gossamer Bio, Alector and BioNTech also joined the billion-plus valuation club.

Half of top IPOs were cancer-focussed, followed by genetic diseases.

2020 forecast remains uncertain, for now.

9 views0 comments


bottom of page